RXRXRecursion Pharmaceuticals - Class A4.01-0.02 (-0.5%)
Recursion Pharmaceuticals - Class A will report earnings after the market closes. View Calendar The market is expecting a ±13.5% move after earnings are reported. The average move for the past 4 quarters of earnings has been ±3.4%. View Expected Move (Conf Call: Nov 3 8:00 AM)
Unusual Option Volume
RXRXRecursion Pharmaceuticals - Class A4.33+0.28 (+6.9%)
Recursion Pharmaceuticals - Class A trades 10,338 contracts. RXRX will report earnings on Nov 2, 2026. The company has the following event: Collaborative Group of the Americas on Inherited Gastrointestinal Cancer (CGA-IGC) Annual Meeting on Nov 2, 2026.
RXRX3.62-0.54 (-13.0%)Recursion Pharmaceuticals - Class A
ATM straddle for 23-Oct-26 expiration returned a positive 50.1% from the previous business day
The upside wing (25 delta calls) declined -61.5%
Downside put (25 delta puts) gained 233.3%
The company has the following event: Collaborative Group of the Americas on Inherited Gastrointestinal Cancer (CGA-IGC) Annual Meeting on Nov 2, 2026.
The option volume for 23-Oct-26 expiration is 5,001
I noticed a lot of bearish pressure coming from the options market on $RXRX. Check out this order imbalance! -176 K option volume delta. What is option volume delta?
RXRX4.36+0.41 (+10.4%)Recursion Pharmaceuticals - Class A
ATM straddle for 16-Oct-26 expiration returned a positive 51.0% from the previous business day
The upside wing (25 delta calls) gained 183.3%
Downside put (25 delta puts) lost -66.7%
The company has the following event: Collaborative Group of the Americas on Inherited Gastrointestinal Cancer (CGA-IGC) Annual Meeting on Nov 2, 2026.
The option volume for 16-Oct-26 expiration is 8,017
$RXRX is facing a lot of negative pressure with an imbalance of -283 K. Learn more about net option delta
